Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Generating New Evidence to Reduce Major Complications to Improve the Safety and Efficacy of ECMO in Severe Cardiac and Respiratory Failure (RECOMMEND)

NCT06526533 is registered in ClinicalTrials.gov with Australian and New Zealand Intensive Care Research Centre as lead sponsor.

NCT NCT06526533
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06526533 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Generating New Evidence to Reduce Major Complications to Improve the Safety and Efficacy of ECMO in Severe Cardiac and Respiratory Failure (RECOMMEND)
Lead sponsor
Australian and New Zealand Intensive Care Research Centre
Phase
Phase 3
Overall status
Recruiting
Start date
March 23, 2026
Completion date
June 30, 2029
Enrollment
600 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

ards (acute respiratory distress syndrome), cardiac arrest (ca), critical illness, extracorporeal membrane oxygenation complication, intensive care medicine